Stock Earnings

Question 1

Abbott Laboratoriesの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Abbott Laboratoriesの総資産は$81,414で、純profitは$13,402です。

Question 2

ABTの主要な財務比率は何ですか？

Accepted Answer

Abbott Laboratoriesの流動比率は2.41、純利益率は31.94、1株当たり売上高は$23.99です。

Question 3

Abbott Laboratoriesの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Abbott Laboratories largest revenue segment is Established Pharmaceutical Products, at a revenue of 5,194,000,000 in the most earnings release.For geography, United States is the primary market for Abbott Laboratories, at a revenue of 16,323,000,000.

Question 4

Abbott Laboratoriesは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Abbott Laboratoriesの純profitは$13,402です。

Question 5

Abbott Laboratoriesに負債はありますか？

Accepted Answer

yes、Abbott Laboratoriesの負債は33,750です。

Question 6

Abbott Laboratoriesの発行済株式数は何株ですか？

Accepted Answer

Abbott Laboratoriesの総発行済株式数は1,731.69株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	43,843	41,950	40,109	43,653	43,075	34,608
Revenue Growth (YoY)	6%	5%	-8%	1%	24%	8%
Cost of Revenue	19,209	18,644	17,919	19,083	18,490	14,967
Gross Profit	24,634	23,306	22,190	24,570	24,585	19,641
Selling, General & Admin	12,021	11,651	10,883	11,109	11,217	9,676
Research & Development	2,867	2,784	2,619	2,741	2,733	2,403
Operating Expenses	16,613	16,313	15,468	15,863	15,997	14,211
Other Non Operating Income (Expenses)	602	558	518	366	277	-12
Pretax Income	8,138	7,013	6,664	8,306	8,211	4,968
Income Tax Expense	-5,839	-6,389	941	1,373	1,140	471
Net Income	13,977	13,402	5,723	6,933	7,071	4,495
Net Income Growth	142%	134%	-17%	-2%	56.99%	22%
Shares Outstanding (Diluted)	1,749	1,748	1,749	1,764	1,789	1,786
Shares Change (YoY)	0%	0%	-1%	-1%	0%	0%
EPS (Diluted)	8.01	7.67	3.27	3.93	3.95	2.52
EPS Growth	143%	135%	-17%	-1%	56.99%	22%
Free Cash Flow	6,917	6,351	5,059	7,804	8,648	5,724
Free Cash Flow Per Share	3.95	3.63	2.89	4.42	4.83	3.2
Gross Margin	56.18%	55.55%	55.32%	56.28%	57.07%	56.75%
Operating Margin	18.29%	16.66%	16.75%	19.94%	19.93%	15.69%
Profit Margin	31.87%	31.94%	14.26%	15.88%	16.41%	12.98%
Free Cash Flow Margin	15.77%	15.13%	12.61%	17.87%	20.07%	16.53%
EBITDA	9,746	8,871	8,688	10,720	10,635	7,562
EBITDA Margin	22.22%	21.14%	21.66%	24.55%	24.68%	21.85%
D&A For EBITDA	1,725	1,878	1,966	2,013	2,047	2,132
EBIT	8,021	6,993	6,722	8,707	8,588	5,430
EBIT Margin	18.29%	16.66%	16.75%	19.94%	19.93%	15.69%
Effective Tax Rate	-71.74%	-91.1%	14.12%	16.53%	13.88%	9.48%

Abbott Laboratories (ABT) Price

ABT Stock Price Chart

ABT Income

Follow-Up Questions